Nymox Pharmaceutical Market Cap

Nymox Pharmaceutical has a market cap or net worth of $13.71 million as of April 1, 2025. Its market cap has decreased by -51.01% in one year.

Market Cap

13.71M

Enterprise Value

16.27M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.14

Market Cap Chart

Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 13.71M, a decrease of -88.39%. That is a compound annual growth rate of -7.57%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	13.71M	45.00%
Dec 31, 2024	9.45M	-82.82%
Dec 29, 2023	55.03M	86.49%
Dec 30, 2022	29.51M	-73.23%
Dec 31, 2021	110.23M	-42.54%
Dec 31, 2020	191.84M	24.63%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.88B
Endo Inc.	1.82B
Nika Pharmaceuticals	1.02B
Veradigm	739.36M
Elite Pharmaceuticals	464.70M
Glass House Brands	383.49M
Northwest Biotherapeutics	309.83M
CytoDyn	283.28M

Market Cap Rankings